Factors affecting incomplete remission after concurrent chemoradiation in advance cervical cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20220226001

Enrollment

900

Registered

2022-02-26

Start date

2011-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advance cervical cancer patient came to hospital with late presentation. Cause of poor outcome and survival. We aimed to determine risk factor effect to incomplete remission after CCRT Cervical Carcinoma, Radiation, Remission

Interventions

Patient with residual tumor after concurrent chemoradiation.,Patient with no residual tumor after concurrent chemoradiation.

Other,Other

Patient with incomplete remission,Patient with complete remission

Eligibility

Sex/Gender

Female

Age

10 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with cervical cancer stage 2-4 after concurrent chemoradiation between 1 Janury 2011-30 April 2021 and could follow clinical until 30 November 2021

Exclusion criteria

Exclusion criteria: Patient with poor ECOG or refuse or incomplete treatment.

Design outcomes

Primary

Measure	Time frame
Remission at 1 month after treatment. Univariate and multivariate regression analysis	—

Secondary

Measure	Time frame
Survival 10 year Cox regression analysis	—

Countries

Thailand

Contacts

Public ContactSunaree Pitchaiprasert

Surin hospital

psunaree@gmail.com044511757

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026